Realbotix Reports Financial Results for Q2-2026
Go back to Realbotix Reports Financial Results for Q2-2026| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 0.88 -0.01 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.89 | 52 Week High | $0.00 | |||
| Open | $0.87 | 52 Week Low | $0.00 | |||
| Day High | $0.89 | P/E | N/A | |||
| Day Low | $0.85 | EPS | $0.00 | |||
| Volume | 152,230 | |||||
| (AMEX: XBOTF) | Delayed: 0.25 +0.01 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.24 | 52 Week High | $ | |||
| Open | $0.28 | 52 Week Low | $ | |||
| Day High | $0.28 | P/E | N/A | |||
| Day Low | $0.24 | EPS | $ | |||
| Volume | 194,302 | |||||
